Top Markets
Coin of the day
Tricida, Inc. Tricida, Inc.

Tricida, Inc.

TCDA
Rang in aandelen #35026
Tricida, Inc. operates as a biopharmaceutical firm with a primary focus on the... Tricida, Inc. operates as a biopharmaceutical firm with a primary focus on the advancement and market introduction of veverimer (TRC101). This compound, an orally ingested, non-systemic polymer, has successfully concluded its Phase III clinical trials. Veverimer is designed to address metabolic acidosis in individuals suffering from chronic kidney disease by specifically targeting and eliminating excess acid within the gastrointestinal tract. The company was established in 2013 and is headquartered in South San Francisco, California.
Aandeelprijs
$0.108
Laatst gesynchroniseerd: 2023-01-23
Marktkapitalisatie
$4.56M
Verandering (1 dag)
-10.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Tricida, Inc. (TCDA)

Categorie

Dividendrendementgeschiedenis voor Tricida, Inc. (TCDA)
Het dividendrendement (TTM) van Tricida, Inc. (aandelsymbool: TCDA) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Tricida, Inc. (TCDA) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten